ÂÜÀòÂÒÂ×

Hagai Marmor-Kollet serves as a Senior Scientist at Massachusetts General Hospital and Harvard Medical School since February 2024 and holds roles as Principal Scientist and Consultant at 1E Therapeutics since July 2021, where leadership in the Structure-Activity Relationship campaign and contributions to funding efforts have been significant. Previous experience includes co-founding the Weizmann Biotech Club, serving as a Teaching Assistant at the Weizmann Institute, and as an Associate Researcher at Rosetta Genomics, focusing on molecular diagnostics in cancer. Military service includes a captaincy in the Golani Brigade of the Israel Defense Forces. Hagai Marmor-Kollet earned a PhD in Molecular Biology from the Weizmann Institute and holds a Master's Degree and Bachelor's Degree in related scientific fields.